Pathogens in the Blood Supply
New York Academy of Sciences Webinar
29 March 2011
Both Judy Mikovits and Ian Lipkin presented at this webinar. Lipkin's slides were not available, so there was no visual aid - but his presentation was on hunting pathogens, not XMRV specific. Judy was talking about XMRV detection and disease association.
These are taken from my hastily typed notes. Any errors are mine, and I cannot guarantee 100% accuracy. I have also had to interpret some of it, so I may have introduce bias - I hope not, but there is no substitute for listening to it or a word for word transcript.
Lipkin
Lipkin reported on intestinal biopsies in autism spectrum distorder, and they are finding a deficiency in enzymes for the metabolism and transport of sugars. Because of sugar alterations this may result in the dysbiosis that is frequently seen.
Lipkin was asked something like five questions, four were directly or indirectly about XMRV. He did not give answers that are very relevant to us, except for the upcoming study on XMRV. Three labs have been met with and had an agreed plan, the same for six clinicians. The hold up has been getting approvals, especially from Stanford and Harvard - but they should be ready to go soon.
Mikovits
Mikovits covered a lot of ground. Much of it is well known and I shall not report it again. I will however touch on the high points of the anti-contamination findings, even if is already well known.
1. They have measured high levels viral proteins from patients.
2. 30% of ME/CFS patients have two strains of viruses.
3. APOBEC3G induces G to A hypermutation, but while this mutates the viral RNA, the resulting amino acid sequence is frequently unaltered, and the virus can still be transmitted. APOBEC3G just reduces the viral load.
4. Diseases associated with XMRV -
mcl
thymoma (a thymus cancer)
melodysplasia
lymphoma
itp ( ideopathic thrombocytopenia, 50% in one study had XMRV)
cll
itp
5. All 60 cell lines at the WPI have been tested for XMRV and are not contaminated.
6. Something Lipkin had also noticed, copathogens can increase severity.
7. Patient contacts including caretakers have higher risk of XMRV so this might be considered as a screening criteria for blood donations.
8. A question about XMRV transmission noted that an implication of CROI is that XMRV might be airborne. This is being investigated, but is not proven.
9. Mikovits is talking to Dr. Lerner about XMRV and herpes virus interactions.
10. Mikovits describes ME/CFS as an Aquired Immune Deficiency.
11. A new high security lab may enable research they have not been able to do so far.
12. It was confirmed that Chronix have indeed claimed to have found fully integrated XMRV in ME/CFS, including flanking DNA on both sides of the virus.
13. Pathogenicity is not proven. However, it is suspected that antivirual methylation might be removed by epigenetic factors including those induced by the virus itself.
The rest of the presentation was not of much relevance to ME/CFS, but there was a long presentation on babesia which might be of interest to some. This is still ongoing, but I thought I would post as I doubt much of importance to us will be said in the remainder.
Bye
Alex